Acura Pharmaceuticals Inc. (ACUR) Profile

Profile for Acura Pharmaceuticals Inc. (ACUR)


Business Description: Acura Pharmaceuticals, Inc is a pharmaceutical company, which is engaged in the research, development and manufacture of product candidates providing abuse deterrent features and benefits.

Address:	616 North. North Court, Suite 120, Palatine, IL, 60067
Telephone:	(847) 705-7709	Website:	www.halseydrug.com
Facsimile:	N/A	Email:	investors@acurapharm.com


Details

CEO:	Robert B. Jones
Employees:	15	Market Cap:	146.83 m
Issue Type:	CS
Auditor:	BDO USA, LLP
Last Audit:	Unqualified
Indices:	Drug Delivery


Industry Classifications

Sector:	Healthcare	CIK:	0000786947
Industry:	Drugs
Sub-Industry:	Drug Delivery
NAICS:	Pharmaceutical Preparation Manufacturing (325412)
SIC:	Pharmaceutical Preparations (2834)

Tags for Acura Pharmaceuticals Inc.

Research stocks or mutual funds related to Acura Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to ACUR. The keywords below have been associated to ACUR by either user submission or electronic means.

life sciences market research biotechnology company pharmaceuticals research pharmaceuticals international research pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics pharmaceutical investment biotechnology market europe pharmaceuticals pharmaceutical research and development pharmaceutical manufacturing company dupont pharmaceuticals pharma marketing pharmaceuticals germany pharma manufacturing pharmaceutical market share pharma license buprenorphine pfizer pharmaceutical company kv pharmaceutical company pharmaceuticals supply chain european pharmaceutical pharmaceutical cro pharma companies pharmaceutical sales pharma pharmaceutical distributors company patent pharmaceutical development pharmaceutical sales rep And Druggists' Sundries (5122) pharmaceutical consultant biotech Drugs pharmaceutical auctions pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation contract pharmaceutical pharmaceutical industry biotech contract Suboxone pharmaceutical sale biopharmaceutical market patent research glaxo pharmaceutical pharmaceutical advances

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.